All Type of News
Baekjae drug wholesaler to reshuffle its organization.
Baekjae, one of the leading pharmaceutical wholesalers in Korea, may run the organization under the new professional leadership from 2003.
According to Baekjae Mr. Kim Dong-goo, the vice chairman of the company an...
KOSDAQ-listed Hwail Pharm selected as best technology-owned enterprise
Hwail Pharm said that it was recently selected from the Korea Technology Credit Guarantee Fund (KTCGF) as the best technology-based firm.
The selection for better technology-owned enterprises is regarded as an auth...
KFDA's action plans for drug safety controls.
The KFDA may fully exert for the domestic pharmaceutical industry to get into a leading nation over the world in the new drug research and development by strengthening the industry support and the drug safety administ...
Foreign-invested pharmaceutical firms are turning to outsourcing
Influenced by subsequent reductions in reimbursed drug prices and expected business downturn until the first half of next year, foreign-invested pharmaceutical firms are turning their eyes to the outsourcing as a way ...
Questions arise on antiulcerant effect of COX-2 inhibitor
Cyclooxygenase-2 (COX-2) inhibitor, a novel nonsteroidal anti-inflammatory drug (NSAID), has been used to treat arthritis by highlighting its advantage in advertisement over other NSAIDs in that COX-2 inhibitor causes...
Kuhnpoong Pharm to change its company name to Schnell Korea
Kuhnpoong pharm says it will change its company name to Schnell Korea in early next year and Schnell means "rapid" in German.
A Kuhnpoong official said, "Our regular shareholders meeting decided to change our comp...
Irassen tablet, placenta nutrient product, to make successful sales.Korea Mypharm Pharmaceutical Co. has built a sound management ground to leap up further just during the past one year since the company inauguration, showing that their marketin...
|
Notice to our readers
Due to vacation English Yakup Daily will not publish January 1(Wednesday) 2003, thru January 2(Thursday), 2003.
We resume publication on January 3(Friday), 2003.
Happy new year!
- management-
Factive tab. approved by KFDA as the fifth new drug in Korea
The Korea Foood and Drug Administration (KFDA) said on December 27 that it approved LG Life Sciences's Factive tab.(gemifloxacin), a novel fluoroquinolone antibiotic with potent, broad-spectrum antimicrobial activity....
Rules concerning screening of safety and efficacy on drugs to be eased
The Korea Food and Drug Administration (KFDA) said it would re-draft the current rules concerning the screening of safety and efficacy on drugs, in line with the introduction of simplified protocol system for drugs, e...
